Injectables and Facelifts: Can We Coexist? A Retrospective Chart Review Assessing Injectable Treatments Preceding and Following Rhytidectomy.
Abstract
[BACKGROUND] Facelift surgery is a cornerstone of facial rejuvenation, yet it may not fully address volume loss, skin quality, or other age-related changes. Minimally invasive procedures-such as injectables and energy-based devices-are increasingly utilized before and after facelift surgery, though their impact on surgical outcomes remains uncertain.
[OBJECTIVE] The objective of this single-center retrospective pilot study is to describe patterns of minimally invasive procedures among patients undergoing facelift surgery in a real-world clinical setting and identify areas for future investigations regarding their potential influence on surgical outcomes.
[METHODS] We analyzed data from 20 patients who underwent facelift surgery and had a documented history of neurotoxin, filler, biostimulator, or energy-based device treatment. Data included patient demographics, treatment history, surgical details, and post-operative satisfaction. Given the limited sample size and retrospective design, the analyses done were descriptive and exploratory in nature.
[RESULTS] All patients received neurotoxin prior to facelift, 90% received hyaluronic-acid filler, and 55% received poly-L-lactic acid or calcium hydroxylapatite. Following surgery, all patients resumed neurotoxin use, and 60% received filler treatments within the first post-operative year. No reported significant surgical complications occurred because of prior filler or biostimulator treatments, and patient satisfaction was high for facelift outcomes.
[CONCLUSION] Within our small, retrospective cohort, prior injectable or energy-based device use was not associated with an increased risk of observable adverse surgical outcomes; however, the limited sample size precludes definitive assessment of safety or risk. Larger, prospectively designed studies are warranted to validate these early observations and optimally define best practices for combining surgical and nonsurgical rejuvenation.
[OBJECTIVE] The objective of this single-center retrospective pilot study is to describe patterns of minimally invasive procedures among patients undergoing facelift surgery in a real-world clinical setting and identify areas for future investigations regarding their potential influence on surgical outcomes.
[METHODS] We analyzed data from 20 patients who underwent facelift surgery and had a documented history of neurotoxin, filler, biostimulator, or energy-based device treatment. Data included patient demographics, treatment history, surgical details, and post-operative satisfaction. Given the limited sample size and retrospective design, the analyses done were descriptive and exploratory in nature.
[RESULTS] All patients received neurotoxin prior to facelift, 90% received hyaluronic-acid filler, and 55% received poly-L-lactic acid or calcium hydroxylapatite. Following surgery, all patients resumed neurotoxin use, and 60% received filler treatments within the first post-operative year. No reported significant surgical complications occurred because of prior filler or biostimulator treatments, and patient satisfaction was high for facelift outcomes.
[CONCLUSION] Within our small, retrospective cohort, prior injectable or energy-based device use was not associated with an increased risk of observable adverse surgical outcomes; however, the limited sample size precludes definitive assessment of safety or risk. Larger, prospectively designed studies are warranted to validate these early observations and optimally define best practices for combining surgical and nonsurgical rejuvenation.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | facelift
|
안면거상술 | dict | 6 | |
| 시술 | filler
|
필러 주입술 | dict | 4 | |
| 시술 | rhytidectomy
|
안면거상술 | dict | 1 | |
| 시술 | facial rejuvenation
|
안면거상술 | dict | 1 | |
| 해부 | skin
|
scispacy | 1 | ||
| 재료 | calcium hydroxylapatite
|
칼슘하이드록시아파타이트 | dict | 1 | |
| 재료 | poly-l-lactic acid
|
폴리락트산 | dict | 1 | |
| 약물 | calcium
|
C0006675
calcium
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Facelift
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | neurotoxin
|
scispacy | 1 | ||
| 약물 | hyaluronic-acid
|
scispacy | 1 | ||
| 질환 | volume loss
|
scispacy | 1 | ||
| 기타 | Facelifts
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | neurotoxin
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
MeSH Terms
Humans; Retrospective Studies; Rhytidoplasty; Female; Dermal Fillers; Middle Aged; Rejuvenation; Hyaluronic Acid; Skin Aging; Pilot Projects; Male; Polyesters; Durapatite; Treatment Outcome; Patient Satisfaction; Aged; Adult; Botulinum Toxins, Type A; Neurotoxins
📑 인용 관계
이 논문이 참조한 문헌 19
- Optimizing Aesthetic Facial Surgery Outcomes Following Minimally Invasive Treatments: Guidelines for…
- Hyaluronic Acid Filler Longevity in the Mid-face: A Review of 33 Magnetic Resonance Imaging Studies.
- Potential Effects of Repetitive Panfacial Filler Injections on Facelift Surgery and Surgical Outcome…
- Ancillary Procedures to Facelift Surgery: What has Changed?
- Hyaluronic Acid Filler Incidentally Found During Mohs Micrographic Surgery: Observations in 36 Patie…
- Long-term MRI Follow-up of Hyaluronic Acid Dermal Filler.
- The Utilization of Poly-l-Lactic Acid as a Safe and Reliable Method for Volume Maintenance After Fac…
- Autologous fat grafting: Latest insights.
- Nonsurgical Facial Rejuvenation Procedures in Patients Under 50 Prior to Undergoing Facelift: Habits…
- Preoperative Risk Factors and Complication Rates in Facelift: Analysis of 11,300 Patients.
- Current Trends in Facial Rejuvenation: An Assessment of ASPS Members' Use of Fat Grafting during Fac…
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Choroidal ischemia after self-injection of hyaluronic acid filler.
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.
- Intra-articular therapies for synovial joint dysfunction: a comprehensive integrative review.